Thrombolytic Agents in Development

This publication has 71 references indexed in Scilit:

• Dose finding with a novel recombinant plasminogen activator (BM 06,022) in patients with acute myocardial infarction: Results of the German recombinant plasminogen activator study
  Journal of the American College of Cardiology, 1994
• Functional properties of recombinant staphylokinase variants obtained by site-specific mutagenesis of methionine-26
  Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1994
• Coronary thrombolysis with K1K2PU, a chimeric tissue-type and urokinase-type plasminogen activator
  Coronary Artery Disease, 1993
• Open, noncontrolled dose-finding study with a novel recombinant plasminogen activator (BM 06.022) given as a double bolus in patients with acute myocardial infarction
  The American Journal of Cardiology, 1993
• Mapping of the catalytic site of CHO‐t‐PA and the t‐PA variant BM 06.022 by synthetic inhibitors and substrates
  Protein Science, 1992
• Amino acid sequence of fibrolase, a direct‐acting fibrinolytic enzyme from agkistrodon contortrix contortrix venom
  Protein Science, 1992
• The plasminogen activator family from the salivary gland of the vampire bat Desmodus rotundas: cloning and expression
  Gene, 1991
• Thrombolytic Properties of a Novel Modified Human Tissue-Type Plasminogen Activator (E6010)
  Journal of Cardiovascular Pharmacology, 1991
• Conjugation to an antifibrin monoclonal antibody enhances the fibrinolytic potency of tissue plasminogen activator in vitro
  Biochemistry, 1988
• Thrombolysis by a fibrin-specific antibody fab′-urokinase conjugate
  Journal of Molecular and Cellular Cardiology, 1987